Label-free characterization of an extracellular vesicle-based therapeutic

32Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Interest in mesenchymal stem cell derived extracellular vesicles (MSC-EVs) as therapeutic agents has dramatically increased over the last decade. Current approaches to the characterization and quality control of EV-based therapeutics include particle tracking techniques, Western blotting, and advanced cytometry, but standardized methods are lacking. In this study, we established and verified quartz crystal microbalance (QCM) as highly sensitive label-free immunosensing technique for characterizing clinically approved umbilical cord MSC-EVs enriched by tangential flow filtration and ultracentrifugation. Using QCM in conjunction with common characterization methods, we were able to specifically detect EVs via EV (CD9, CD63, CD81) and MSC (CD44, CD49e, CD73) markers. Furthermore, analysis of QCM dissipation versus frequency allowed us to quantitatively determine the ratio of marker-specific EVs versus non-vesicular particles (NVPs) – a parameter that cannot be obtained by any other technique so far. Additionally, we characterized the topography and elasticity of these EVs by atomic force microscopy (AFM), enabling us to distinguish between EVs and NVPs in our EV preparations. This measurement modality makes it possible to identify EV sub-fractions, discriminate between EVs and NVPs, and to characterize EV surface proteins, all with minimal sample preparation and using label-free measurement devices with low barriers of entry for labs looking to widen their spectrum of characterization techniques. Our combination of QCM with impedance measurement (QCM-I) and AFM measurements provides a robust multi-marker approach to the characterization of clinically approved EV therapeutics and opens the door to improved quality control.

References Powered by Scopus

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

14596Citations
N/AReaders
Get full text

Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

7750Citations
N/AReaders
Get full text

Optimized exosome isolation protocol for cell culture supernatant and human plasma

1342Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Technology insight: Plant-derived vesicles—How far from the clinical biotherapeutics and therapeutic drug carriers?

145Citations
N/AReaders
Get full text

Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy

112Citations
N/AReaders
Get full text

Single-cell RNA landscape of the osteoimmunology microenvironment in periodontitis

94Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Priglinger, E., Strasser, J., Buchroithner, B., Weber, F., Wolbank, S., Auer, D., … Gimona, M. (2021). Label-free characterization of an extracellular vesicle-based therapeutic. Journal of Extracellular Vesicles, 10(12). https://doi.org/10.1002/jev2.12156

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 15

54%

Professor / Associate Prof. 7

25%

Researcher 6

21%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 10

45%

Neuroscience 4

18%

Agricultural and Biological Sciences 4

18%

Medicine and Dentistry 4

18%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free